GUJINJECPharmaceuticals
Gujarat Inject Kerala Ltd — Profit & Loss Statement
₹78.21
+0.68%
Gujarat Inject Kerala Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Gross Profit | 1.27 Cr | 0.39 Cr | 0.02 Cr | 70762.00 | — |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -3904.46 | 0.00 | — |
| Tax Rate For Calcs | 0.19 | 0.21 | 0.26 | 0.25 | — |
| Normalized EBITDA | 1.26 Cr | 0.11 Cr | 0.06 Cr | 29498.00 | — |
| Net Income From Continuing Operation Net Minority Interest | 1.02 Cr | 0.08 Cr | 0.04 Cr | 22098.00 | — |
| Reconciled Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Reconciled Cost Of Revenue | 17.78 Cr | 5.40 Cr | 0.15 Cr | 0.02 Cr | — |
| EBITDA | 1.26 Cr | 0.11 Cr | 0.06 Cr | 29498.00 | — |
| EBIT | 1.26 Cr | 0.11 Cr | 0.06 Cr | 29498.00 | — |
| Net Interest Income | -15000.00 | -4000.00 | 129.00 | -206.00 | — |
| Interest Expense | 15000.00 | 4000.00 | 0.00 | 0.00 | — |
| Normalized Income | 1.02 Cr | 0.08 Cr | 0.04 Cr | 22098.00 | — |
| Net Income From Continuing And Discontinued Operation | 1.02 Cr | 0.08 Cr | 0.04 Cr | 22098.00 | — |
| Total Expenses | 17.97 Cr | 5.74 Cr | 0.55 Cr | 0.07 Cr | — |
| Diluted NI Availto Com Stockholders | 1.02 Cr | 0.08 Cr | 0.04 Cr | 22098.00 | — |
| Net Income Common Stockholders | 1.02 Cr | 0.08 Cr | 0.04 Cr | 22098.00 | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 1.02 Cr | 0.08 Cr | 0.04 Cr | 22098.00 | — |
| Minority Interests | 0.00 | 0.00 | 0.00 | — | — |
| Net Income Including Noncontrolling Interests | 1.02 Cr | 0.08 Cr | 0.04 Cr | 22098.00 | — |
| Net Income Discontinuous Operations | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Continuous Operations | 1.02 Cr | 0.08 Cr | 0.04 Cr | 22098.00 | — |
| Tax Provision | 0.24 Cr | 0.02 Cr | 0.01 Cr | 7400.00 | — |
| Pretax Income | 1.25 Cr | 0.11 Cr | 0.06 Cr | 29498.00 | — |
| Other Non Operating Income Expenses | 0.18 Cr | 0.06 Cr | 0.43 Cr | 0.05 Cr | — |
| Net Non Operating Interest Income Expense | -15000.00 | -4000.00 | 129.00 | -206.00 | — |
| Interest Expense Non Operating | 15000.00 | 4000.00 | 0.00 | 0.00 | — |
| Operating Income | 1.08 Cr | 0.04 Cr | -0.38 Cr | -0.05 Cr | — |
| Operating Expense | 0.19 Cr | 0.34 Cr | 0.40 Cr | 0.05 Cr | — |
| Other Operating Expenses | 0.13 Cr | 0.31 Cr | 0.37 Cr | 0.04 Cr | — |
| Depreciation And Amortization In Income Statement | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Depreciation Income Statement | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Cost Of Revenue | 17.78 Cr | 5.40 Cr | 0.15 Cr | 0.02 Cr | — |
| Total Revenue | 19.05 Cr | 5.79 Cr | 0.17 Cr | 0.02 Cr | — |
| Operating Revenue | 19.05 Cr | 5.79 Cr | 0.17 Cr | 0.02 Cr | — |
| Total Unusual Items | — | 0.00 | -15000.00 | 0.00 | 0.00 |
| Total Unusual Items Excluding Goodwill | — | 0.00 | -15000.00 | 0.00 | 0.00 |
| Interest Income | — | 2803.00 | 630.00 | 0.00 | 0.00 |
| Diluted Average Shares | — | 1.18 Cr | 0.49 Cr | 0.49 Cr | 0.49 Cr |
| Basic Average Shares | — | 1.18 Cr | 0.49 Cr | 0.49 Cr | 0.49 Cr |
| Diluted EPS | — | 0.07 | 0.05 | 0.00 | -0.12 |
| Basic EPS | — | 0.07 | 0.05 | 0.00 | -0.12 |
| Special Income Charges | — | 0.00 | -15000.00 | 0.00 | 0.00 |
| Total Other Finance Cost | — | 4447.00 | 501.00 | 206.00 | — |
| Interest Income Non Operating | — | 2803.00 | 630.00 | 0.00 | 0.00 |
| Selling General And Administration | — | 0.31 Cr | 0.37 Cr | 0.04 Cr | 0.11 Cr |
| Selling And Marketing Expense | — | 87039.00 | 0.00 | 0.00 | 0.00 |
| General And Administrative Expense | — | 0.30 Cr | 0.37 Cr | 0.04 Cr | 0.11 Cr |
| Write Off | — | — | 15000.00 | — | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Gujarat Inject Kerala Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.